Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis.

Saved in:

Bibliographic Details
Title:	Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis.
Authors:	Vagapova ER; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia. vr.elmira@gmail.com.; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia. vr.elmira@gmail.com., Lebedev TD; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia.; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia., Prassolov VS; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia.; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Source:	Scientific reports [Sci Rep] 2021 Aug 30; Vol. 11 (1), pp. 17658. Date of Electronic Publication: 2021 Aug 30.
Publication Type:	Published Erratum
Journal Info:	Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE; PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2045-2322
DOI:	10.1038/s41598-021-97281-9